In:
Therapeutic Advances in Cardiovascular Disease, SAGE Publications, Vol. 2, No. 1 ( 2008-02), p. 43-52
Abstract:
Drug-eluting stents (DES) in percutaneous coronary interventions significantly reduce rates of restenosis and the need for new revascularizations compared with bare metal stents. However, as the use of DES has increased dramatically, questions have been raised about their long-term safety. Concerns about an increased risk of late stent thrombosis, particularly beyond the first year of treatment, have arisen and have been exacerbated by sparse and conflicting information, and boosted an intense debate between cardiologists. In this article, we reviewed the most recent information to clarify the conundrum of late stent thrombosis and the long-term safety of DES.
Type of Medium:
Online Resource
ISSN:
1753-9447
,
1753-9455
DOI:
10.1177/1753944707088158
Language:
English
Publisher:
SAGE Publications
Publication Date:
2008
detail.hit.zdb_id:
2387507-0
Permalink
